Abstract:Simple Summary Gastric cancer (GC) is one of the most common malignancies of the digestive system and ranks third among the causes of cancer-related death worldwide. Local deep invasion or distant metastasis in gastric cancer is usually associated with poor prognosis. Therefore, it is imperative to explore the mechanisms of GC metastasis. In this study, we identified that insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) overexpression in GC tissues was significantly associated with the deterioration of survival in GC patients. We then proved that IGF2BP2 accelerated the epithelial-mesenchymal transition (EMT) of GC by directly interacting with HMGA1 mRNA. Our findings suggest that IGF2BP2 may play an important role in the metastasis of GC. As an RNA-binding protein, insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) is involved in enhancing the progression of a few malignant tumors by recognizing N6-methyladenosine on targeted RNA. However, the specific effects of IGF2BP2 on gastric cancer (GC) and the underlying mechanisms remain unclear. In this study, the expression level of IGF2BP2 was evaluated by analyzing data from a public database and performing immunohistochemical staining with GC specimens. The effect of IGF2BP2 on GC cell metastasis was investigated by Transwell assays and animal studies. RNA immunoprecipitation (RIP) was performed to identify potential mRNA bound to IGF2BP2. The levels of these identified RNAs were measured by RT-PCR, while corresponding proteins were quantified via Western blot. It was revealed that IGF2BP2 expression in GC tissues was significantly upregulated, and its overexpression was significantly associated with worse survival in GC patients. The aberrant expression of IGF2BP2 was demonstrated to promote the invasion and metastasis of GC cells by both in vivo and in vitro experiments. In subsequent experiments, it was then verified that by directly interacting with HMGA1 mRNA, IGF2BP2 augmented its stability and thus increased its expression. The knocking down of IGF2BP2 could significantly decrease the migration and invasion of GC cells, which could be reversed by increasing HMGA1 expression. Additionally, both in vitro and in vivo epithelial-mesenchymal transition (EMT) of GC cells were enhanced by IGF2BP2/HMGA1 axis. In conclusion, it was proven in our study that the IGF2BP2/HMGA1/EMT axis contributed to GC metastasis, suggesting its potential as a novel predictive and therapeutic biomarker for GC.

EIF2S2 transcriptionally upregulates HIF1α to promote gastric cancer progression via activating PI3K/AKT/mTOR pathway

MEF2D Facilitates Liver Metastasis of Gastric Cancer Cells Through Directly Inducing H1X under IL-13 Stimulation

High Expression of EIF4G2 Mediated by the TUG1/hsa-miR-26a-5p Axis is Associated with Poor Prognosis and Immune Infiltration of Gastric Cancer

IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer

IGF2BP3 promotes the progression of gastric cancer by activating cGMP-PKG signaling pathway via targeting FBXO32

The Tumor Promoting Roles of Erythropoietin/erythropoietin Receptor Signaling Pathway in Gastric Cancer

EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.

Increased Expression of EHF Via Gene Amplification Contributes to the Activation of HER Family Signaling and Associates with Poor Survival in Gastric Cancer

LGALS9B stabilizes EEF1D protein and activates the PI3K/AKT signaling pathway to promote gastric cancer occurrence and metastasis

Elevated mRNA level indicates FSIP1 promotes EMT and gastric cancer progression by regulating fibroblasts in tumor microenvironment

Altered expression of hypoxia-inducible factor-1α (HIF-1α) and its regulatory genes in gastric cancer tissues.

Overexpression of eukaryotic elongation factor 1 alpha-2 is associated with poorer prognosis in patients with gastric cancer

EphA2 Promotes Epithelial–mesenchymal Transition Through the Wnt/β-catenin Pathway in Gastric Cancer Cells

Eukaryotic translation initiation factor EIF3H potentiates gastric carcinoma cell proliferation.

Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis

Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients

Transcriptional Up-Regulation of RhoE by Hypoxia-Inducible Factor (HIF)-1 Promotes Epithelial to Mesenchymal Transition of Gastric Cancer Cells During Hypoxia

RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13

E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes

EIF4A3-induced Circle RNA_ 0001860 Promotes Growth, Invasion, and Immune Evasion of Gastric Cancer Cells Through the Mir-618/Hmga2 Axis

Hif-1 Alpha And Hif-2 Alpha Correlate With Migration And Invasion In Gastric Cancer